Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
2008
2009
2010
Announcements
Articles
Articles and Publications
Campaign
Case Studies
Charge Capture and Pricing
Coding Integrity
Company
Consulting
Craneware Insights Articles
Education
Home
Journey
News & Events
Opportunities
Other
post
Press Releases
Products
Services
Testimonial
Trade Shows
Uncategorized
Uncategorized
Upcoming Events
Value Cycle
Webinars
White Papers

Purchase of Shares and Exercise of Share Options

18 August 2020 – The Board of Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, announces that on 17 August 2020, Keith Neilson, CEO of the Company, purchased 7,710 ordinary shares of 1p each in the capital of the Company (“Ordinary Shares”) at a price of 1,740 pence per Ordinary Share.

Additionally, on 14 August 2020, Mr Neilson also exercised options over 13,383 Ordinary Shares at an exercise price of 401 pence per Ordinary Share. Mr Neilson, having paid the exercise price and associated taxation liabilities, has retained all shares.

As a result of both these transactions, Mr Neilson has increased his holdings in the Company by 21,093 Ordinary Shares and now holds 3,418,599 Ordinary Shares, representing 12.7% of the Company’s issued share capital.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:

  1. Details of the Restricted Person / person closely associated with him or her
  2. a) Name Keith Neilson
 
  1. Reason for the notification
  2. a) Position / status CEO
  3. b) Initial notification / Amendment Initial notification
 
  1. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
  2. a) Name Craneware plc
  3. b) LEI 213800O2CTJ1YFXNXG05
 
  1. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
 
  1. a) Description of the financial instrument, type of
instrument                                                         Ordinary Shares of 1p each in the capital of Craneware plc  
  1. b) Identification code ISIN GB00B2425G68
 
  1. c) Nature of the transaction Exercise of options over Ordinary Shares
 
  1. d) Price(s) and volume(s) Volume(s) 13,383, Price(s) £4.01
 
  1. e) Aggregated information: N/A (single transaction)
  2. Aggregated volume –
  3. Price –
 
  1. f) Date of the transaction 2020-08-14
 
  1. g) Place of the transaction Outside a trading venue
 
  1. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
 
  1. a) Description of the financial instrument, type of
instrument                                                         Ordinary Shares of 1p each in the capital of Craneware plc  
  1. b) Identification code ISIN GB00B2425G68
 
  1. c) Nature of the transaction Purchase of Ordinary Shares
 
  1. d) Price(s) and volume(s) Volume(s) 7,710, Price(s) £17.40
 
  1. e) Aggregated information: N/A (single transaction)
  2. Aggregated volume –
  3. Price –
 
  1. f) Date of the transaction 2020-08-17
 
  1. g) Place of the transaction London Stock Exchange (XLON)
For further information, please contact:
Craneware plc
+44 (0)131 550 3100
Keith Neilson, CEO
Craig Preston, CFO
Peel Hunt (NOMAD and Joint Broker)
+44 (0)20 7418 8900
Dan Webster
George Sellar
Andrew Clark
Investec Bank (Joint Broker)
+44 (0)20 7597 5970
Patrick Robb Sebastian Lawrence
Henry Reast
Alma (Financial PR)
+44 (0)203 405 0205
Caroline Forde
Robyn Fisher
Helena Bogle

About Craneware

Craneware (AIM: CRW.L), the leader in automated value cycle solutions, collaborates with U.S. healthcare providers to plan, execute and monitor value-based economic performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 350 staff. Craneware’s value cycle management suite includes charge capture, strategic pricing, patient engagement, claims analytics, revenue recovery and retention, and cost and margin intelligence solutions.

Learn more at www.craneware.com